MARC details
000 -LEADER |
fixed length control field |
03275cam a2200397 i 4500 |
001 - CONTROL NUMBER |
control field |
19826536 |
003 - CONTROL NUMBER IDENTIFIER |
control field |
OSt |
005 - DATE AND TIME OF LATEST TRANSACTION |
control field |
20200220074251.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
fixed length control field |
170724s2018 enk b 001 0 eng |
010 ## - LIBRARY OF CONGRESS CONTROL NUMBER |
LC control number |
2017950105 |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
International Standard Book Number |
9780198803539 |
040 ## - CATALOGING SOURCE |
Original cataloging agency |
DLC |
Language of cataloging |
eng |
Description conventions |
rda |
Transcribing agency |
DLC |
042 ## - AUTHENTICATION CODE |
Authentication code |
pcc |
043 ## - GEOGRAPHIC AREA CODE |
Geographic area code |
n-us--- |
050 00 - LIBRARY OF CONGRESS CALL NUMBER |
Classification number |
KF8925.P7 |
Item number |
H47 2018 |
082 ## - DEWEY DECIMAL CLASSIFICATION NUMBER |
Classification number |
346.73038 HER |
100 1# - MAIN ENTRY--PERSONAL NAME |
Personal name |
Herrmann, Mark, |
Relator term |
author. |
245 10 - TITLE STATEMENT |
Title |
Drug and device product liability litigation strategy / |
Statement of responsibility, etc. |
Mark Herrmann, David B. Alden, Geoffrey M. Drake. |
250 ## - EDITION STATEMENT |
Edition statement |
Second edition. |
264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE |
Place of production, publication, distribution, manufacture |
Oxford, United Kingdom : |
Name of producer, publisher, distributor, manufacturer |
Oxford University Press, |
Date of production, publication, distribution, manufacture, or copyright notice |
2018. |
300 ## - PHYSICAL DESCRIPTION |
Extent |
lxiii, 406 pages ; |
Dimensions |
26 cm. |
336 ## - CONTENT TYPE |
Content type term |
text |
Content type code |
txt |
Source |
rdacontent |
337 ## - MEDIA TYPE |
Media type term |
unmediated |
Media type code |
n |
Source |
rdamedia |
338 ## - CARRIER TYPE |
Carrier type term |
volume |
Carrier type code |
nc |
Source |
rdacarrier |
504 ## - BIBLIOGRAPHY, ETC. NOTE |
Bibliography, etc. note |
Includes bibliographical references and index. |
505 8# - FORMATTED CONTENTS NOTE |
Formatted contents note |
Machine generated contents note: -- Acknowledgments -- 1. Introduction -- 2. The FDA's Regulation of Prescription Drugs and Devices -- 3. Pre-litigation Counseling -- 4. Legal Issues & Theories -- 5. Consolidated Proceedings -- 6. Aggregated Proceedings - Class Actions -- 7. Aggregated Proceedings - Multidistrict Litigation -- 8. Fact Discovery -- 9. Expert Retention and Discovery -- 10. Expert Testimony, Rule 702, And Daubert -- 11. Preemption -- 12. The Learned Intermediary Doctrine -- 13. Motions In Limine -- 14. Jury Selection -- 15. The Trial Of A Drug Or Device Case -- Table of Authorities -- Index. |
520 ## - SUMMARY, ETC. |
Summary, etc. |
"Each year, thousands of lawsuits are filed in federal and state courts seeking recovery from manufacturers of pharmaceuticals and medical devices. These lawsuits include individual actions, actions consolidated into multidistrict litigation, and class actions. The litigation occasionally becomes life-threatening for the defendant corporations, and may breed a public relations nightmare, as occurred with Vioxx, breast implants, and fen-phen. Drug & Device Product Liability Litigation Strategy, by Mark Herrmann and David B. Alden, offers assistance to lawyers who practice in this high-stakes, high-profile, and rapidly-evolving area. The book's primary focus is to provide useful practice pointers and overall strategic guidance for attorneys involved in product liability litigation for prescription drugs and medical devices. It will serve as an indispensable guide to handling such a case from pre-litigation through trial. The legal landscape in this important area is expected to shift as the Supreme Court's decisions in Riegel v. Medtronic, Inc. and Wyeth v. Levine are applied, and as the President and Congress address tort reform and other health care issues. Practitioners will need thoughtful, expert advice to navigate these changes"-- |
Assigning source |
Provided by publisher. |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Products liability |
General subdivision |
Medical instruments and apparatus |
Geographic subdivision |
United States |
General subdivision |
Trial practice. |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Products liability |
General subdivision |
Drugs |
Geographic subdivision |
United States |
General subdivision |
Trial practice. |
700 1# - ADDED ENTRY--PERSONAL NAME |
Personal name |
Alden, David B., |
Relator term |
author. |
700 1# - ADDED ENTRY--PERSONAL NAME |
Personal name |
Drake, Geoffrey M., |
Relator term |
author. |
906 ## - LOCAL DATA ELEMENT F, LDF (RLIN) |
a |
7 |
b |
cbc |
c |
origcop |
d |
2 |
e |
epcn |
f |
20 |
g |
y-gencatlg |
942 ## - ADDED ENTRY ELEMENTS (KOHA) |
Source of classification or shelving scheme |
Dewey Decimal Classification |
Koha item type |
BOOKs |